We have observed
3 EP applications
Sharon Claire Baldock
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after July 23, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
OLIGOMER-OPIOID AGONIST CONJUGATES
LIPID-CONTAINING PSA COMPOSITIONS, METHODS OF ISOLATION AND METHODS OF USE THEREOF
Oligomer-opioid agonist conjugates